Abstract The Human Connectome Project (HCP) was launched in 2010 as an ambitious
effort to accelerate advances in human neuroimaging, particularly for measures of brain …

Depression is a common mental disorder characterized by heterogeneous cognitive and
behavioral symptoms. The emerging research paradigm of functional connectomics has …

Background and objective Repetitive transcranial magnetic stimulation (rTMS) is a first-line
treatment for treatment-resistant depression (TRD). The mechanisms of action of rTMS are …

Functional neuroimaging research on depression has traditionally targeted neural networks
associated with the psychological aspects of depression. In this study, instead, we focus on …

Background Electroconvulsive therapy (ECT) is an effective neuromodulatory treatment for
major depressive disorder (MDD), especially for cases resistant to antidepressant drugs …

Brain function depends on the flexible and dynamic coordination of functional subsystems
within distributed neural networks operating on multiple scales. Recent progress has been …

Background Electroconvulsive therapy (ECT) is considered the most effective treatment for
major depressive disorder (MDD). In recent years, the pursuit of the neurobiological …

Brain parcellations play a crucial role in the analysis of brain imaging data sets, as they can
significantly affect the outcome of the analysis. In recent years, several novel approaches for …

No tools are currently available to predict whether a patient suffering from major depressive
disorder (MDD) will respond to a certain treatment. Machine learning analysis of magnetic …

Transcranial magnetic stimulation (TMS) is an approved intervention for treatment-resistant
depression (TRD), but current targeting approaches are only partially successful. Our …